Agentix Corp. SEC filings AGTX
Agentix Corp. has 153 filings in SEC EDGAR's recent list, going back to Apr 1, 2014. Its latest annual report, Form 10-K, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 14, 2022 (officer or director change). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Jun 14, 2022 | Jun 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 21, 2021 | Dec 20, 2021 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jul 16, 2021 | Jul 14, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 14, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Material agreement
|
May 27, 2021 | May 21, 2021 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Sep 9, 2020 | May 28, 2020 |
| 8-K |
Current report
Other events
|
Jul 30, 2020 | Jun 15, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2020 | Jul 2, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control
|
May 29, 2020 | May 28, 2020 |
| 8-K |
Current report
Officer or director change
|
May 13, 2020 | May 8, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 11, 2019 | Jul 10, 2019 |
| 8-K |
Current report
Officer or director change
|
Jun 11, 2019 | Jun 10, 2019 |
| 8-K |
Current report
Auditor change
|
Dec 10, 2018 | Dec 6, 2018 |
| 8-K |
Current report
Officer or director change
|
Nov 16, 2018 | Nov 14, 2018 |
| 8-K |
Current report
Auditor change
|
Jan 5, 2016 | Jan 5, 2016 |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AGTX (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Dana Point, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1603345
- Former names
- FairWind Energy Inc. (until Jun 27, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.